These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


378 related items for PubMed ID: 10666371

  • 21. Molecular genetics of radiographically defined de novo glioblastoma multiforme.
    Tortosa A, Ino Y, Odell N, Swilley S, Sasaki H, Louis DN, Henson JW.
    Neuropathol Appl Neurobiol; 2000 Dec; 26(6):544-52. PubMed ID: 11123721
    [Abstract] [Full Text] [Related]

  • 22. Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis.
    Edamoto Y, Hara A, Biernat W, Terracciano L, Cathomas G, Riehle HM, Matsuda M, Fujii H, Scoazec JY, Ohgaki H.
    Int J Cancer; 2003 Sep 01; 106(3):334-41. PubMed ID: 12845670
    [Abstract] [Full Text] [Related]

  • 23. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
    Hlobilkova A, Ehrmann J, Sedlakova E, Krejci V, Knizetova P, Fiuraskova M, Kala M, Kalita O, Kolar Z.
    Neoplasma; 2007 Sep 01; 54(4):334-41. PubMed ID: 17822324
    [Abstract] [Full Text] [Related]

  • 24. Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression.
    Gorgoulis VG, Zacharatos P, Kotsinas A, Liloglou T, Kyroudi A, Veslemes M, Rassidakis A, Halazonetis TD, Field JK, Kittas C.
    Am J Pathol; 1998 Dec 01; 153(6):1749-65. PubMed ID: 9846966
    [Abstract] [Full Text] [Related]

  • 25. Genetic pathways to glioblastoma: a population-based study.
    Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, Di Patre PL, Burkhard C, Schüler D, Probst-Hensch NM, Maiorka PC, Baeza N, Pisani P, Yonekawa Y, Yasargil MG, Lütolf UM, Kleihues P.
    Cancer Res; 2004 Oct 01; 64(19):6892-9. PubMed ID: 15466178
    [Abstract] [Full Text] [Related]

  • 26. Alterations of cell cycle regulators in gliomatosis cerebri.
    Mawrin C, Kirches E, Schneider-Stock R, Boltze C, Vorwerk CK, von Mawrin A, Kirches E, Schneider-Stock R, Boltze C, Vorwerk CK, von Mawrin A, Kirches E, Schneider-Stock R, Boltze C, Vorwerk CK, von Mawrin A, Kirches E, Schneider-Stock R, Boltze C, Vorwerk CK, von Deimling A, Stoltenburg-Didinge G, Bornemann A, Romeike B, Sellhaus B, Dietzmann K.
    J Neurooncol; 2005 Apr 01; 72(2):115-22. PubMed ID: 15925990
    [Abstract] [Full Text] [Related]

  • 27. CDK4 and MDM2 gene alterations mainly occur in highly proliferative and aggressive mantle cell lymphomas with wild-type INK4a/ARF locus.
    Hernández L, Beà S, Pinyol M, Ott G, Katzenberger T, Rosenwald A, Bosch F, López-Guillermo A, Delabie J, Colomer D, Montserrat E, Campo E.
    Cancer Res; 2005 Mar 15; 65(6):2199-206. PubMed ID: 15781632
    [Abstract] [Full Text] [Related]

  • 28. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.
    Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A, Louis DN.
    Cancer Res; 1996 Jan 01; 56(1):150-3. PubMed ID: 8548755
    [Abstract] [Full Text] [Related]

  • 29. Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A.
    Fuxe J, Akusjärvi G, Goike HM, Roos G, Collins VP, Pettersson RF.
    Cell Growth Differ; 2000 Jul 01; 11(7):373-84. PubMed ID: 10939591
    [Abstract] [Full Text] [Related]

  • 30. Combined analysis of p53 and RB pathways in epithelial ovarian cancer.
    Hashiguchi Y, Tsuda H, Yamamoto K, Inoue T, Ishiko O, Ogita S.
    Hum Pathol; 2001 Sep 01; 32(9):988-96. PubMed ID: 11567230
    [Abstract] [Full Text] [Related]

  • 31. Establishment and characterization of a human cell line from paediatric cerebellar glioblastoma multiforme.
    Di Tomaso E, Pang JC, Lam HK, Tian XX, Suen KW, Hui AB, Hjelm NM.
    Neuropathol Appl Neurobiol; 2000 Feb 01; 26(1):22-30. PubMed ID: 10736064
    [Abstract] [Full Text] [Related]

  • 32. TP53 alterations in relation to the cell cycle-associated proteins p21, cyclin D1, CDK4, RB, MDM2, and EGFR in cancers of the uterine corpus.
    Skomedal H, Kristensen GB, Nesland JM, Børresen-Dale AL, Tropé C, Holm R.
    J Pathol; 1999 Apr 01; 187(5):556-62. PubMed ID: 10398121
    [Abstract] [Full Text] [Related]

  • 33. Use of human tissue to assess the oncogenic activity of melanoma-associated mutations.
    Chudnovsky Y, Adams AE, Robbins PB, Lin Q, Khavari PA.
    Nat Genet; 2005 Jul 01; 37(7):745-9. PubMed ID: 15951821
    [Abstract] [Full Text] [Related]

  • 34. Amplification of the STOML3, FREM2, and LHFP genes is associated with mesenchymal differentiation in gliosarcoma.
    Nagaishi M, Kim YH, Mittelbronn M, Giangaspero F, Paulus W, Brokinkel B, Vital A, Tanaka Y, Nakazato Y, Legras-Lachuer C, Lachuer J, Ohgaki H.
    Am J Pathol; 2012 May 01; 180(5):1816-23. PubMed ID: 22538188
    [Abstract] [Full Text] [Related]

  • 35. Molecular features of adult glioma associated with patient race/ethnicity, age, and a polymorphism in O6-methylguanine-DNA-methyltransferase.
    Wiencke JK, Aldape K, McMillan A, Wiemels J, Moghadassi M, Miike R, Kelsey KT, Patoka J, Long J, Wrensch M.
    Cancer Epidemiol Biomarkers Prev; 2005 Jul 01; 14(7):1774-83. PubMed ID: 16030116
    [Abstract] [Full Text] [Related]

  • 36. Molecular characterization of PDGFR-alpha/PDGF-A and c-KIT/SCF in gliosarcomas.
    Reis RM, Martins A, Ribeiro SA, Basto D, Longatto-Filho A, Schmitt FC, Lopes JM.
    Cell Oncol; 2005 Jul 01; 27(5-6):319-26. PubMed ID: 16373964
    [Abstract] [Full Text] [Related]

  • 37. Molecular genetic analysis of giant cell glioblastomas.
    Meyer-Puttlitz B, Hayashi Y, Waha A, Rollbrocker B, Boström J, Wiestler OD, Louis DN, Reifenberger G, von Deimling A.
    Am J Pathol; 1997 Sep 01; 151(3):853-7. PubMed ID: 9284834
    [Abstract] [Full Text] [Related]

  • 38. Amplification and overexpression of MDM2 in primary (de novo) glioblastomas.
    Biernat W, Kleihues P, Yonekawa Y, Ohgaki H.
    J Neuropathol Exp Neurol; 1997 Feb 01; 56(2):180-5. PubMed ID: 9034372
    [Abstract] [Full Text] [Related]

  • 39. Genetic alterations commonly found in diffusely infiltrating cerebral gliomas are rare or absent in pleomorphic xanthoastrocytomas.
    Kaulich K, Blaschke B, Nümann A, von Deimling A, Wiestler OD, Weber RG, Reifenberger G.
    J Neuropathol Exp Neurol; 2002 Dec 01; 61(12):1092-9. PubMed ID: 12484572
    [Abstract] [Full Text] [Related]

  • 40. Abnormalities of p16, p15 and CDK4 genes in recurrent malignant astrocytomas.
    Saxena A, Robertson JT, Ali IU.
    Oncogene; 1996 Aug 01; 13(3):661-4. PubMed ID: 8760309
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 19.